Clinical Trial Detail

NCT ID NCT02943317
Title Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors Verastem, Inc.
Indications

peritoneum cancer

fallopian tube cancer

ovary epithelial cancer

Therapies

Defactinib

Avelumab

Age Groups: adult senior

No variant requirements are available.